COOThe Cooper Companies, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 13647
Ticker: COO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1983-01-21
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: COO

Detail

Enriched 2026-08-14 20:47

Market cap: $14,964,700,239.9
Shares outstanding (class): 195,030,630
Shares outstanding (weighted): 195,030,630
SIC: 3851 OPHTHALMIC GOODS
Employees: 15,000
Location: SAN RAMON, CA
Homepage: https://www.coopercos.com
Description: CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Market cap and share counts drift.

Funds holding this security

330 funds · 335 positions · $4.82B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$442.62M	0.02%	6,190,519 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$356.01M	0.03%	4,979,114 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$321.69M	0.20%	4,499,163 NS	FIGI
T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC.	—	$305.32M	1.36%	4,270,200 NS	FIGI
New Perspective Fund New Perspective Fund	—	$257.92M	0.17%	3,607,314 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$204.84M	0.34%	2,864,852 NS	FIGI
T. Rowe Price Mid-Cap Value Fund, Inc. T. ROWE PRICE MID-CAP VALUE FUND, INC.	—	$204.14M	1.38%	2,855,143 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$180.19M	0.03%	2,520,165 NS	FIGI
N/A —	—	$161.94M	0.02%	2,264,919 NS	FIGI
Franklin Mutual Shares Fund Franklin Mutual Series Funds	—	$134.24M	2.01%	1,877,499 NS	FIGI
Touchstone Funds Group Trust-Touchstone Mid Cap… Touchstone Funds Group Trust	—	$123.52M	2.82%	1,727,579 NS	FIGI
Janus Henderson Enterprise Fund JANUS INVESTMENT FUND	—	$120.05M	0.59%	1,678,964 NS	FIGI
Franklin Mutual Beacon Fund Franklin Mutual Series Funds	—	$114.57M	3.39%	1,602,363 NS	FIGI
Bridge Builder Large Cap Growth Fund Bridge Builder Trust	—	$111.59M	0.42%	1,560,645 NS	FIGI
American Balanced Fund American Balanced Fund	—	$107.44M	0.04%	1,502,592 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCOO
FIGI_COMPOSITEBBG000BG3445
FIGI_SHARE_CLASSBBG001S5Q1H6
CIK0000711404
ISINUS2166485019
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Medical Devices
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The Cooper Companies is a medical device manufacturer focused on contact lenses and ophthalmic products.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.